Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

Completed · Phase 2

Conditions studied: Major Depressive Disorder

In brief

This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.

Key facts

Study ID

NCT00742573

Run by

New York State Psychiatric Institute

People needed

170

Starts

2008-08-01

Expected to finish

2014-01-10

Last updated by the study team

2020-03-03

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hispanic males and females
• DSM-IV criteria for non-psychotic major depressive disorder (MDD) of at least moderate severity (HAM-D-17> 18)
• 18- 79
• Patients with stable dosage of Benzodiazepines to treat anxiety disorders

You may not qualify if…

• At risk of attempting suicide
• Unstable medical illness
• History of bipolar disorder, schizophrenia, or other psychotic disorder
• Pregnant or lactating
• Alcohol or substance use disorder that requires acute detoxification

Where it is running

• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.